British drugmaker Moderna steps on the accelerator with major funding
Moderna Moderna is setting out to revolutionise health care by developing a vaccine which targets specific proteins on a surface protein of viruses that cause cancer. The company’s first cancer-fighting vaccine, called CoVID-19, was…